Drug Insight: Steroids in CNS Infectious Diseases -- New Indications for an Old Therapy CME

Disclosures

Release Date: January 30, 2008Valid for credit through January 30, 2009
Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s) for physicians

Contents of This CME Activity
    The content of this CME activity, "Drug Insight: Steroids in CNS Infectious Diseases -- New Indications for an Old Therapy," was developed by the faculty.

    To participate in this activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

    There is good evidence for the efficacy of corticosteroid treatment for central nervous system (CNS) infections. The current review highlights the use of corticosteroids for different types of CNS infection.

  1. Drug Insight: Steroids in CNS Infectious Diseases -- New Indications for an Old Therapy
    Michael T. Fitch, MD, PhD
    Diederik van de Beek, MD, PhD

Go to Test Questions

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2008 Medscape.

 

WebMD

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Identify the corticosteroid most recommended for treatment of central nervous system (CNS) infections
  2. Describe research into steroid treatment for bacterial meningitis
  3. Specify treatment recommendations for steroid therapy for tuberculous meningitis
  4. Describe the clinical presentation of CNS infections with herpes simplex virus
  5. Specify treatment recommendations for steroid therapy for herpes simplex viral encephalitis
Authors and Disclosures

Michael T. Fitch, MD, PhD
Disclosure: Michael T. Fitch, MD, PhD, has disclosed no relevant financial relationships.


Diederik van de Beek, MD, PhD
Disclosure: Diederik van de Beek, MD, PhD, has disclosed no relevant financial relationships.


Charles P. Vega, MD
Disclosure: Charles P. Vega, MD, has disclosed that he has served as an advisor or consultant to Novartis, Inc.


 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.